Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    YS Biopharma Co. Ltd.

    NASDAQ: YS · Real-Time Price · USD
    1.02
    0.09 (9.68%)
    At close: May 24, 2024, 10:00 PM

    YS Biopharma Income Statement

    Financials in CNY. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Revenue
    		 687.2M 502.95M 257.02M
    Cost of Revenue
    		 153.36M 117.07M 59.66M
    Gross Profit
    		 533.84M 385.88M 197.36M
    Operating Income
    		 -139.38M -118.96M -125.85M
    Interest Income
    		 n/a n/a n/a
    Pretax Income
    		 -144.35M -101.07M -174.37M
    Net Income
    		 -145.48M -106M -191.83M
    Selling & General & Admin
    		 333.32M 272.77M 208.33M
    Research & Development
    		 318.7M 211.22M 94.39M
    Other Expenses
    		 -199.45K -2.41M -22.36M
    Operating Expenses
    		 647.15M 481.82M 319.68M
    Interest Expense
    		 30.86M 2.72M 29.69M
    Selling & Marketing Expenses
    		 251.56M 165.72M 69.44M
    Cost & Expenses
    		 800.51M 598.89M 379.33M
    Income Tax Expense
    		 1.13M 4.94M 17.45M
    Shares Outstanding (Basic)
    		 93.06M 92.17M 92.17M
    Shares Outstanding (Diluted)
    		 93.06M 92.17M 92.17M
    EPS (Basic)
    		 -1.56 -1.15 -2.08
    EPS (Diluted)
    		 -1.56 -1.15 -2.08
    EBITDA
    		 -76.82M -67.2M -116.78M
    EBIT
    		 -108.7M -118.65M -161.29M
    Depreciation & Amortization
    		 36.69M 31.15M 27.91M

    Add to Watchlist